Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We conducted a network meta-analysis to evaluate the efficacy and safety of oral antidiabetic drugs (OADs) for gestational diabetes. DATA SOURCES: We searched PubMed, the Cochrane Library, ClinicalTrials.gov, and related reviews from inception to October 2014. STUDY SELECTION: We included randomized clinical trials comparing efficacy and safety between different OADs or OADs vs insulin in patients with gestational diabetes. DATA SYNTHESIS: We included 18 randomized clinical trials. Traditional and network meta-analyses were performed to compare different OADs or OADs vs insulin. Traditional meta-analyses confirmed that there was no significant difference in maternal fasting blood glucose or glycated hemoglobin levels in patients treated with insulin, metformin, and glyburide. Compared to insulin, metformin was associated with lower maternal weight gain (weighted mean difference [WMD], -1.49 kg; 95% confidence interval [CI], -2.26 to -0.31), shorter gestational age (WMD, -0.16 wk; 95% CI, -0.30 to -0.03), and increased incidence of premature birth (odds ratio [OR], 1.63; 95% CI, 1.07 to 2.48). Compared to insulin, glyburide was associated with higher neonatal birth weight (WMD, 130.68 g; 95% CI, 55.98 to 205.38), increased incidence of neonatal hypoglycemia (OR, 2.64; 95% CI, 1.59 to 4.38), and increased incidence of macrosomia (OR, 3.09; 95% CI, 1.59 to 6.04). Network meta-analysis revealed that glyburide was associated with higher maternal weight gain, higher neonatal birth weight, increased incidence of neonatal hypoglycemia, and increased incidence of macrosomia than was metformin. CONCLUSION: Both metformin and glyburide are suitable for use in the management of gestational diabetes because of good glycemic control. However, glyburide treatment is associated with increased risk of neonatal hypoglycemia, high maternal weight gain, high neonatal birth weight, and macrosomia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M. (2011) · Diabetes Care · doi:10.2337/dc11-0660 · Cited by 379
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
Lowe, L. P., Metzger, B. E., Dyer, A. R., Lowe, J., McCance, D. R., Lappin, T. R. J., Trimble, E. R., Coustan, D. R., Hadden, D. R., Hod, M., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1687 · Cited by 367
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Placental passage of metformin in women with polycystic ovary syndrome
Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245
Wu, H.-Y., Huang, J.-W., Lin, H.-J., Liao, W.-C., Peng, Y.-S., Hung, K.-Y., Wu, K.-D., Tu, Y.-K., & Chien, K.-L. (2013) · BMJ · doi:10.1136/bmj.f6008 · Cited by 233
Metformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222
Ijäs, H., Vääräsmäki, M., Morin-Papunen, L., Keravuo, R., Ebeling, T., Saarela, T., & Raudaskoski, T. (2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02763.x · Cited by 215
Niromanesh, S., Alavi, A., Sharbaf, F. R., Amjadi, N., Moosavi, S., & Akbari, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.031 · Cited by 203
Randomized trial of metformin vs insulin in the management of gestational diabetes
Spaulonci, C. P., Bernardes, L. S., Trindade, T. C., Zugaib, M., & Francisco, R. P. V. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.022 · Cited by 183
Metformin Compared With Glyburide in Gestational Diabetes: A Randomized Controlled Trial
Moore, L. E., Clokey, D., Rappaport, V. J., & Curet, L. B. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181c52132 · Cited by 177
Landon, M. B., & Gabbe, S. G. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31823974e2 · Cited by 175
Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T., & Rönnemaa, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12017 · Cited by 174
Perinatal outcomes and the use of oral hypoglycemic agents
Bertini, A. M., Silva, J. C., Taborda, W., Becker, F., Bebber, F. R. L., Viesi, J. M. Z., Aquim, G., & Ribeiro, T. E. (2005) · Journal of Perinatal Medicine · doi:10.1515/jpm.2005.092 · Cited by 161
Dhulkotia, J. S., Ola, B., Fraser, R., & Farrell, T. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.06.044 · Cited by 145
Liang, W., Wu, X., Fang, W., Zhao, Y., Yang, Y., Hu, Z., Xue, C., Zhang, J., Zhang, J., Ma, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085245 · Cited by 134
Moore, L. E., Briery, C. M., Clokey, D., Martin, R. W., Williford, N. J., Bofill, J. A., & Morrison, J. C. (2007) · PubMed · Cited by 123
Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Poolsup, N., Suksomboon, N., & Amin, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092485 · Cited by 118
Metformin compared with glyburide for the management of gestational diabetes
Silva, J. C., Pacheco, C., Bizato, J., de Souza, B. V., Ribeiro, T. E., & Bertini, A. M. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.04.028 · Cited by 115
Silva, J. C., Fachin, D. R. R. N., Coral, M. L., & Bertini, A. M. (2012) · jpme · doi:10.1515/jpm-2011-0175 · Cited by 109
Zeng, C., Li, H., Yang, T., Deng, Z., Yang, Y., Zhang, Y., Ding, X., & Lei, G. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.06.028 · Cited by 107
Anjalakshi, C., Balaji, V., Balaji, M. S., & Seshiah, V. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.031 · Cited by 104
Lain, K. Y., Garabedian, M. J., Daftary, A., & Jeyabalan, A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.038 · Cited by 100
The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis
Zeng, Y.-C., Li, M.-J., Chen, Y., Jiang, L., Wang, S.-M., Mo, X.-L., & Li, B.-Y. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.03.001 · Cited by 76
Comparison of Glyburide versus Insulin in Management of Gestational Diabetes Mellitus
Ogunyemi, D. A., Jesse, M., & Davidson, M. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.427 · Cited by 74
Glyburide as treatment option for gestational diabetes mellitus
Tempe, A., & Mayanglambam, R. D. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12042 · Cited by 71
Contraindications to use of metformin
(2003) · BMJ · doi:10.1136/bmj.326.7392.762/a · Cited by 60
Su, D. F., & Wang, X. Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.056 · Cited by 57
Self-citationWang, X., Wang, X., Liu, T., He, Q., Wang, Y., & Zhang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091327 · Cited by 51
Self-citationGlibenclamida no tratamento do diabete melito gestacional em estudo comparado à insulina
Silva, J. C., Bertini, A. M., Taborda, W., Becker, F., Bebber, F. R. L., Aquim, G. M. D. C., & Viesi, J. M. Z. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400007 · Cited by 42
Metformin prevents macrosomia and neonatal morbidity in gestational diabetes
Hasan, J. A., Karim, N., & Sheikh, Z. (2012) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.283.1686 · Cited by 39
40: Transplacental transfer of glyburide: is it clinically significant?
Schwartz, R. A., Rosenn, B., Aleksa, K., & Koren, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.214 · Cited by 9
Diabetes mellitus. Medication update.
SLAGLE, M. A. (2002) · PubMed · Cited by 6
Cited by
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“In the same meta-analyses, compared to metformin, glyburide use was associated with increased maternal weight gain, birthweight, macrosomia and neonatal hypoglycemia (361,362).”
Background13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
Metadata
- Authors
- Jiang, Y.-F., Chen, X.-Y., Ding, T., Wang, X.-F., Zhu, Z.-N., & Su, S.-W.
- Affiliations
- Hebei University of Chinese Medicine (CN)
- Hebei Medical University (CN)
- Corresponding author
- Zhu, Zhong-Ning
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-05
- Volume
- 100
- Issue
- 5
- Pages
- 2071-2080
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2129155490
- Cited by
- 124
- References
- 35
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 3 · 2023: 8 · 2022: 9 · 2021: 40 · 2020: 12 · 2019: 7 · 2018: 15 · 2017: 15 · 2016: 3 · 2015: 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Hebei Province
- Department of Health of Hebei Province
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, oral antidiabetic drugs, metformin, glibenclamide, insulin therapy, neonatal hypoglycemia, macrosomia, birth weight, gestational weight gain, glycemic control, HbA1c, preterm birth, gestational age, drug safety comparison, drug efficacy comparison, network meta-analysis of randomized controlled trials
- MeSH terms
- Administration, Oral, Blood Glucose, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.